Trial Shines Light on Questionable Benefits of Tocolytics for Preterm Birth

(MedPage Today) – Aurora, Colorado – was not Atosiban, an anti -oxytocin receptor available in Europe, outperforming the imaginary drug in improving nascent results of premature birth between 30 and 34 weeks, according to the Messenger …